A decade on innovation: the next chapter

Amy Lo is Chairman, Global Wealth Management Asia, Co-Head of Wealth Management Asia Pacific, Head and Chief Executive of UBS Hong Kong, and a Managing Director at UBS. Amy has over 30 years of experience in the banking industry. Since joining UBS in 1995, she has held a number of senior management positions including Regional Head of Ultra High Net Worth and Global Family Office in Asia. Today, the ultra-high net worth business is the leading wealth manager for ultra-high net worth individuals in the region.

Actively involved in the development of the private banking industry in Hong Kong, Amy chairs the Executive Committee of the Hong Kong Private Wealth Management Association (PWMA), and is a Board Member of the Hong Kong Financial Services Development Council (FSDC) and the Hong Kong Academy for Wealth Legacy. She is also a member of the Banking Industry Training Advisory Committee of the Hong Kong Education Bureau and an advisor of Our Hong Kong Foundation.

A passionate supporter of youth education and technological innovation in Greater China, Amy is a member of The Court and the MBA Advisory Board at The University of Hong Kong, and a member of the Advisory Committee of the Department of Social Work at The Chinese University of Hong Kong. She is also a Board Member of the UBS Optimus Foundation, the independent grant-making foundation that helps UBS clients improve the education and welfare of children globally.

In recognition of her contribution to the wealth management industry, Amy was named Private Banker of the Year in the Asian Private Banker Awards for Distinction 2020 and 2023. She also received the Executive Award at the DHL/SCMP Business Awards 2018 for her efforts in building UBS as a corporate citizen in Hong Kong. She was also named by a top-tier Chinese media, China Business News, as one of the "Hong Kong Top 20 in the next 20 years" for her contribution to innovation developments in 2017.

Leon Farrant is the CEO and co-founder of Green Li-ion, a battery recycling and remanufacturing technology provider at the forefront of the industry. With over 15 years of strategic leadership in the energy and service sectors, creating and scaling businesses across diverse regions, Leon is known for his consensus-building prowess, vision, and rigor for global business. He drives Green Li-ion's mission to make battery recycling commercially viable with scalable, on-site solutions. Leon's expertise in innovation and technology application and his active involvement in assessing the financial feasibility of recycling lithium battery circularity, propel Green Li-ion’s efforts to efficiently close the loop on recycling critical battery materials around the globe.

Dr Darko Matovski is a research scientist turned technology entrepreneur known for his pioneering work in Causal AI - a new category of intelligent machines that reason like humans. He is the co-founder and CEO of causaLens, a USD50M venture-backed scaleup headquartered in London.

Darko draws on over a decade of experience across respected institutions such as the UK’s National Physical Laboratory, where he made transformative contributions as an AI researcher. Darko also has experience applying artificial intelligence quantitatively within the financial sector – previously working as a researcher at hedge funds, including a global investment firm managing over USD160 billion in assets.

In addition to leading causaLens’ rapid growth, Darko contributes to the development of ethical AI through his role as a Global Innovator at the World Economic Forum – an international organization that engages world leaders to drive impactful change. Darko is also a member of the Milken Institute's Young Leaders Circle, a network of intellectually curious, motivated, and philanthropic young professionals supporting the Institute's mission and collaborating on global challenges.

Dr Min-Han Tan is the Founder, CEO and Medical Director of Lucence. The Company develops advanced liquid biopsy blood tests that achieve earlier cancer detection for better outcomes, when cure is possible. Lucence is the first and only Asian-headquartered company to receive US government Medicare insurance coverage. Its clinical services are delivered by twin labs in Palo Alto and Singapore across the US and Asia.

Dr Tan is a medical oncologist and clinical cancer geneticist by background, trained in the Cleveland Clinic and National Cancer Center Singapore, and has received many scientific awards for research over 25 years of experience.

Taras Wankewycz has been working on the commercialisation of hydrogen solutions across several sectors over the past 20 years, having founded 3 companies so far since 2003, including Horizon Fuel Cell Technologies, a global green hydrogen leader and now one of the largest vertically integrated producers of PEM fuel cells and AEM electrolyzers in China. This first company has since branched out into several product lines addressing different industry sectors forming several spin-offs around the world. As part of this market diversification, in 2015 Taras created H3 Dynamics to take on the global aviation industry, further specialising technologies to extend the range of electric flight, decarbonize ground operations, and help produce low-carbon synthetic jet fuels.

Philippe Bouaziz is Chairman and CFO of Deel, where he is responsible for managing the company’s corporate strategy, including finance, M&A, legal, and compliance. Founded in 2019, Deel’s all-in-one payroll and HR platform helps companies simplify every aspect of managing an international workforce, from culture and onboarding, to local payroll and compliance. In five years the company has grown to 4000+ team members worldwide in over 100 different countries and raised over USD 600 million in funding. It has 35,000-plus customers, including Reddit, Klarna, and Cloudflare.

Prior to Deel, Philippe founded Prodware Group and is currently Chairman. Listed on Euronext, ProdWare Group is a leading IT powerhouse, helping over 18,000 customers in EMEA with their business software and digital transformation. There he completed over 45 acquisitions and remains Chairman of the Board. Philippe is also Chairman of VC firm Sarona Partners, the largest growth ecosystem for global and Israeli high-tech companies. He is a startup enthusiast with 150+ investments in startups.

Ramtin Attar is the CEO & Co-Founder of Promise Robotics; a pioneering Canadian AI startup that enables the building industry to harness industrialized robotic automation to exponentially increase production of sustainable housing.

Prior to founding Promise Robotics, Ramtin was a Distinguished Research Scientist, a founding member of Autodesk Research, and Head of Autodesk Technology Centre in Canada. During his 13-year career at Autodesk, he led the development of core technologies and strategies in the AEC sector while working with many internal teams and external customers across the globe. Before co-founding Promise Robotics, Ramtin also led Autodesk Moonshots in Industrialized Homebuilding and the expansion of Autodesk's AI and robotics activities in EMEA. A technically savvy CEO, Ramtin is also an inventor and holds multiple patents related to BIM, IoT, Digital Twin, Robotics, and Simulation technologies.

Have been actively involved in research and development of interventional medical devices. Had managed a public company and created a few startups successfully. Holding over 30 patents. Published over 20 papers on polymer materials. Also is an early stage startup investor.

Working Experience

Chairman and CEO, current, HeMo Bioengineering Limited, specialized in neuro interventional technology to treat ischemic stroke.

Former CEO, Biosensors International Group, was a Singapore listed company, hold a various positions during the service from VP of R/D, COO, co-CEO. The company was focusing on interventional cardiovascular disease treatment.

Founder and former CEO, JW Medical Systems, was a private hold company in interventional cardiovascular, one of the top three companies in China market.

Former New Product Development Manager, Johnson and Johnson, managed drug coated cardiovascular stent program.

Former Project Group Leader, Guidant Corporation (today is Abbott), had worked on peripheral and coronary interventional products

Educational Background

PhD in Macromolecular Science from Case Western Reserve University, Ohio
BS in Chemical Engineering from Tsinghua University, Beijing

Xu Zhen is Professor of Biomedical Engineering, Radiology, and Neurosurgery at the University of Michigan, Ann Arbor, She is a co-inventor, pioneer and leader of histotripsy, a non-invasive therapeutic ultrasound technology that uses external ultrasound to liquefy the target tumor to acellular debris. She is also a co-founder of HistoSonics, a USA company to commercialize histotripsy. She has developed histotripsy for cancer, neurological, and cardiovascular applications. Her work has led to the FDA approval of non-invasive histotripsy treatment of liver tumors. She received the IEEE Ultrasonics, Ferroelectrics, and Frequency Control (UFFC) Outstanding Paper Award in 2006, Frederic Lizzi Award from The International Society of Therapeutic Ultrasound (ISTU) in 2015, Fellow of American Institute of Medicine and Bioengineering (AIMBE) in 2019, Lockhart Memorial Prize for Cancer Research in 2020, and IEEE Carl Hellmuth Hertz Ultrasonics Award in 2024. She is an associate editor for IEEE Transactions on UFFC and Frontiers in Biomedical Engineering. She has served as the VP of IEEE Ultrasonics and is an elected board member of ISTU. She has published 130+ peer-reviewed papers and secured USD 40+ millions of external funding. She has 36 issued USA and international patents. HistoSonics’ FDA-approved EdisonTM histotripsy clinical system won the Edison Gold Award in 2024, which is their highest award for top innovators in Health, Medical and Biotechnology. HistoSonics has raised USD 300 millions with 200 employees.

With nearly 20 years' experience working in impact and philanthropy, Tom leads the UBS Social Impact team of over 150 professionals across the globe to help clients and UBS employees to maximize their impact locally and globally. Tom has personally advised over 2,500 clients and their families during his time at UBS and is passionate about finding ways to catalyze scalable solutions to the pressing social and environmental problems the world is facing. A regular speaker at conferences globally, Tom believes that through partnerships we can build an Impact Economy that values people and planet in all investment decisions and builds a world that is profitable for all.

Prior to joining UBS in 2013, Tom spent his career in the non-profit sector. As Director of Philanthropy and Social Investment at the Disability Charity Scope, he pioneered the use of social investment structures, including the Scope Bond which was the first listed bond issued by an operational charity in the UK. Tom also worked with the cabinet office on the development of the new Social Investment Tax Relief. Earlier in his career, Tom was the first UK employee of the Microloan Foundation securing the investment for the charity to expand into sustainable microfinance, with over 50,000 customers in Malawi. Tom, is a father of four children, a keen runner and has a Politics degree from Exeter University as well as professional qualifications in marketing (CIM), fundraising management, financial planning and is a Green and Sustainable Finance professional. Tom is also proud to be #madebydyslexia and to be an advocate for personalized education to help every child achieve their full potential.

Mudit Dandwate, Co-founder and CEO of Dozee (Turtle Shell Technologies Private Limited), a company that aims to simplify and transform healthcare in India and beyond. Proudly Made In India, Dozee is India’s first Contactless Remote Patient Monitoring solution that is steadily and systematically pioneering patient monitoring in hospitals and at home.

A mechanical engineer by education, Mudit graduated from the Indian Institute of Technology, Mumbai in 2013. Before starting Dozee, he worked as a vehicle dynamics expert at Altair Technologies where he designed, built, and raced four full-scale race cars, including India's first electric race cars. Mudit is no stranger to out-of-the-box thinking. He has pioneered an MCC-approved cricket bat which was licensed by Slazenger and is still in use. He also designed his own Thought Controlled Bionic Arm on June 26, 2017, after losing his arm to a crocodile attack in an attempt to save his dog.

Fueled by his passion, he started his Dozee journey in 2015 with Gaurav Parchani, an IIT Indore alumnus. Today, that journey is changing lives for the better across the country and beyond. He is regarded as an unconventional thinker with many firsts to his credit. Under his aegis, Dozee delivers on the promise of making healthcare accessible, affordable, and available to millions of patients.

Regarded as one of the fastest growing health-tech companies globally, Dozee has established a presence in 370+ hospitals covering 40+ districts in India and is now expanding its operations even in Africa.

Mudit has multiple accolades to his credit, to name a few - the Forbes India 30under30 2021, ET Innovation award 2020, Anjani Mashelkar Inclusive Innovation Award 2020 and BML Munjal Award 2022 among others.

Under his leadership, Dozee is now on a mission to drive technology driven transformation to impact millions of lives globally.

Marshall Pribadi, the architect of Indonesia’s Digital Trust, has been instrumental in transforming the nation's approach to bridge the trust in the digital ecosystem. As the founder and CEO of Privy, a startup company that provides digital identity and certified digital signature services, Marshall's journey began with a big vision of the digital ecosystem where everyone can safely use and interact. Eight years into Privy’s journey, it has emerged as the biggest player in Indonesia's digital identity, serving over 51 million verified users and more than 4,000 enterprises. Marshall's commitment to innovation and excellence in digital identity has propelled Privy beyond the Indonesian market. In July 2024, Indonesian Minister of Trade inaugurated Privy's first international office in Sydney. Marshall is also currently serving as the Chairman of Indonesia Regtech and Legaltech Association (IRLA), Vice Chairman of Indonesia Fintech Association (AFTECH), an Endeavor Entrepreneur, and listed in Forbes Asia 30 under 30 in 2017.

Igal Raichelgauz, the visionary Founder and CEO of Autobrains, is a distinguished leader in the realm of artificial intelligence. With a robust background that spans electrical engineering, computer and neuroscience, Igal has been at the forefront of AI innovation. Under his leadership, Autobrains boasts over 250 patents and has raised more than USD 140 million, propelling the company into new global markets.

Igal's professional journey began in elite military intelligence before he co- founded Figment, an advanced messaging platform. He later transitioned to become the CTO of LCB, a speech recognition company. His academic endeavours at the Technion, focusing on cortical neural networks, laid the groundwork for his scientific expertise.

In 2007, Igal co-founded Cortica, an AI firm renowned for its self-learning technology in visual perception. At Cortica, he spearheaded the foundation of seven AI companies in various fields; including Autobrains in the Autonomous Driving domain.

At Autobrains, Igal has pioneered Liquid AI, a cutting-edge technology that addresses key challenges in the automotive AI industry, such as edge cases, cost efficiency, and the integration of perception and decision-making. This innovative approach is reshaping the future of vehicles and mobility.

Igal's significant contributions to technology and innovation have earned him numerous awards, and he is a sought-after speaker at international conferences, where he shares his expertise on the future of AI in the automotive industry and beyond.